跳至主要内容
临床试验/NCT02256163
NCT02256163已完成不适用

Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm (TAA)

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 258 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
258
试验地点
1
主要终点
Impact of known mutations and research of new genes involved in non syndromic TAA

研究概览

简要总结

The primary objectives of the study are

  • to assess the contribution of alteration of each known gene on non-syndromic TAA.
  • to map and identify unknown gene involved in the non-syndromic TAA.

详细描述

The secondary objectives of the study are

  • to study the correlation of phenotype-genotype, in particular, to compare the aortic phenotype of non-syndromic TAA patients and TAA syndromic patients.
  • to develop national standardized strategies of genetic diagnosis and of clinical management using genetic data.

研究设计

研究类型
Observational
观察模型
Family Based
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged > 18 years.
  • Written informed consent obtained.
  • People with health insurance.
  • For individual:
  • people ≥ 45 years, thoracic aortic aneurysm without syndrome,
  • or people > 45 years with familial TAA.
  • For family:
  • At least 2 members of family in 2 generations have TAA without syndrome and at least 2 patients of TAA will undergo blood collection.
  • All people in family will undergo blood collection, each member should declare at first his (her) status (with or without TAA, unknown), the relationship (direct relative family or family in-law), no limit of age. For the children, only those with TAA will perform blood collection for the study.

排除标准

  • Thoracic aortic aneurysm with different syndromes (Marfan syndrome, Ehlers-Danlos syndrome, Loeys-Dietz syndrome, Turner syndrome, Noonan syndrome).
  • Arterial hypertension.

结局指标

主要结局

Impact of known mutations and research of new genes involved in non syndromic TAA

时间窗: 1 year

Research for mutations in known genes such as FBN1, TGFBR1, TGFBR2, ACTA2, or MYH11. Research for new genes in families and in individuals TAA patients without known mutation.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验